What is the difference between NIPT and amniocentesis?

NIPT is a screening test that carries no risk, while amniocentesis is a diagnostic test that provides a definitive answer but carries a small risk of miscarriage.

How early can you do a DNA test before birth?

NIPT can be done as early as 10 weeks of pregnancy. Carrier screening can be done before pregnancy or during the first trimester.

What is the difference between NIPT and amniocentesis?

NIPT is a screening test that carries no risk, while amniocentesis is a diagnostic test that provides a definitive answer but carries a small risk of miscarriage.

How early can you do a DNA test before birth?

NIPT can be done as early as 10 weeks of pregnancy. Carrier screening can be done before pregnancy or during the first trimester.

Can You Do a DNA Test Before Birth? Yes—Here’s What You Need to Know

Q: Can you do a DNA test before birth?

Yes, you can do a DNA test before birth. The most common method is non-invasive prenatal testing (NIPT), which uses a blood draw to analyze cell-free DNA. Other options include carrier screening, CVS, and amniocentesis.

Yes, you can do a DNA test before birth. Learn about NIPT, cell-free DNA, and other prenatal screening options in the US for 2026.

Yes, you can do a DNA test before birth. In 2026, the most common and accurate method is non-invasive prenatal testing (NIPT), which uses a simple blood draw from the mother to analyze cell-free DNA (cfDNA) from the placenta. This test can screen for chromosomal conditions like Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), and Patau syndrome (trisomy 13), as well as determine fetal sex and, in some cases, screen for certain microdeletions. Unlike invasive procedures, NIPT carries zero risk to the pregnancy. Below, we break down your options, what each test reveals, and how to choose the right path.

Understanding Prenatal DNA Testing: The Basics

Prenatal DNA testing falls into two main categories: screening tests and diagnostic tests. Screening tests (like NIPT, first-trimester screening, quad screen, and integrated screening) estimate the risk of a genetic condition. Diagnostic tests (like chorionic villus sampling and amniocentesis) provide a definitive yes-or-no answer but carry a small risk of miscarriage. For most expecting parents, the journey starts with a screening test—and NIPT is the most advanced screening tool available today.

Non-Invasive Prenatal Testing (NIPT) – The Gold Standard

NIPT is a blood test that can be done as early as 10 weeks of pregnancy. It works by sequencing the cell-free DNA fragments that naturally cross the placenta into the mother’s bloodstream. The test is highly accurate (over 99% for the most common trisomies) and is recommended by the American College of Obstetricians and Gynecologists (ACOG) for all pregnant individuals, regardless of age. In 2026, expanded NIPT panels can also screen for sex chromosome aneuploidies (like Turner syndrome) and certain microdeletions (like 22q11.2).

Other Screening Options: First-Trimester, Quad, and Integrated

If NIPT isn’t chosen, other screening tests combine ultrasound with blood markers:

First-trimester screening (11–13 weeks): Uses nuchal translucency ultrasound plus blood tests for PAPP-A and hCG.
Quad screen (15–22 weeks): Blood test measuring four markers (AFP, hCG, uE3, inhibin A) to assess risk for trisomies and neural tube defects.
Integrated screening: Combines first-trimester and second-trimester results into a single risk score.

These are less accurate than NIPT (detection rates around 80–90%) and do not assess fetal DNA directly.

Diagnostic DNA Tests: When They’re Needed

If a screening test shows an increased risk, or if you have a family history of a specific genetic disorder, your provider may recommend a diagnostic test. These analyze the fetal DNA directly from placental or amniotic fluid cells:

Chorionic Villus Sampling (CVS)

CVS is performed at 10–13 weeks. A thin catheter or needle collects a small sample of placental tissue. It can diagnose chromosomal conditions and many single-gene disorders. The risk of miscarriage is about 0.1–0.2% (roughly 1 in 500–1000).

Amniocentesis

Amniocentesis is done at 15–20 weeks. A needle withdraws a small amount of amniotic fluid containing fetal cells. It provides a definitive diagnosis for chromosomal abnormalities and neural tube defects. The miscarriage risk is similarly low (0.1–0.3%).

Important: Both CVS and amniocentesis are invasive and require a referral from a maternal-fetal medicine specialist. A genetic counselor can help you interpret results and decide if these procedures are right for you.

What About Paternity Before Birth?

Yes, you can also do a prenatal paternity test before birth. This is a separate DNA test that compares the fetal cell-free DNA (from the mother’s blood) with a cheek swab from the alleged father. It can be performed as early as 9 weeks and is over 99% accurate. However, this is not a medical screening test—it’s a legal/relationship test, and it’s usually not covered by insurance.

Carrier Screening: A DNA Test for Parents

Another type of DNA test before birth is carrier screening, which tests the parents (not the fetus) for recessive gene mutations. If both parents carry the same mutation, their baby has a 25% chance of inheriting the disorder. Common conditions include cystic fibrosis, fragile X syndrome, spinal muscular atrophy, and sickle cell disease. Carrier screening can be done before pregnancy or during the first trimester, and it’s often combined with NIPT in a comprehensive panel.

Comparison of Prenatal DNA Tests (2026)

Test Type	Timing	Sample	What It Detects	Accuracy	Risk
NIPT (cell-free DNA)	10+ weeks	Maternal blood	Trisomy 21, 18, 13; sex chromosomes; some microdeletions	>99% for common trisomies	None
First-trimester screening	11–13 weeks	Blood + ultrasound	Risk of trisomies 21, 18, 13; neural tube later	~82–87%	None
Quad screen	15–22 weeks	Maternal blood	Risk of trisomies 21, 18; neural tube defects	~80–85%	None
Integrated screening	11–13 + 15–20 weeks	Blood + ultrasound	Combined risk of trisomies and NTDs	~90–95%	None
CVS	10–13 weeks	Placental tissue	Definitive chromosomal and gene diagnosis	>99%	0.1–0.2% miscarriage
Amniocentesis	15–20 weeks	Amniotic fluid	Definitive chromosomal and gene diagnosis	>99%	0.1–0.3% miscarriage

How to Choose the Right DNA Test

Your choice depends on your medical history, family background, and personal preferences. A genetic counselor can guide you, but here are general rules:

If you want maximum information with zero risk, choose NIPT.
If you have a known genetic condition in your family, consider carrier screening first.
If you’re over 35 or have an abnormal ultrasound, NIPT or a diagnostic test may be recommended.
If you need a definitive answer, CVS or amniocentesis are the only options.

Fetal Fraction and Test Reliability

NIPT reliability depends on the fetal fraction—the percentage of cell-free DNA in the mother’s blood that comes from the placenta. This typically ranges from 5–10% after 10 weeks. If the fetal fraction is too low (common in multiple pregnancies, higher maternal weight, or early testing), the lab may report a “no-call” result, and you may need to redo the test. Always discuss your results with a healthcare provider.

2026 Updates in Prenatal DNA Testing

In 2026, NIPT is expanding to include more conditions, such as rare autosomal trisomies and 22q11.2 deletion syndrome. Some labs are now offering whole-genome sequencing of cell-free DNA to identify additional chromosomal imbalances. However, these extended panels have higher false-positive rates, so counseling is essential.

Your Next Step: Order a Comprehensive Panel

If you’re ready to take control of your prenatal care, you can order a prenatal screening panel online that combines NIPT and carrier screening in one simple blood draw. Results are typically available within 7–10 business days, and you’ll receive a detailed report to share with your doctor. Start your journey today for peace of mind.